Suenaga R, Suka M, Hirao T, Hidaka I, et al. Cost-effectiveness of a "treat-all" strategy using Direct-Acting Antivirals
(DAAs) for Japanese patients with chronic hepatitis C genotype 1 at different
fibrosis stages. PLoS One 2021;16:e0248748.
PMID: 33793594